Isolation, Identification and Antibiotic Susceptibility of Bacteria from Upper Respiratory Tract Infections at Dhamar Governorate, Yemen

Fawaz Al-Badaii¹ , Assmaa Al-taibi² , Hafeedha Al-shaeri³ , Ebtisam Homied⁴ , Mawadah Obad⁵ , Fardos Al-khatari⁶ , Shaima Al-khawlani⁷ , Abdulwahab Al Sanabani⁸

Section:Research Paper, Product Type: Journal-Paper
Vol.8 , Issue.2 , pp.12-19, Apr-2021

Online published on Apr 30, 2021

Copyright © Fawaz Al-Badaii, Assmaa Al-taibi, Hafeedha Al-shaeri, Ebtisam Homied, Mawadah Obad, Fardos Al-khatari, Shaima Al-khawlani, Abdulwahab Al Sanabani . This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
 

View this paper at   Google Scholar | DPI Digital Library

XML View     PDF Download

How to Cite this Paper

Abstract :
This study was carried out to isolate and identify the pathogenic bacteria involving URTI as well as to assess the antibiotic susceptibility of bacteria and its correlation of age, sex and study period among patients` swabs. Bacteriological standard methods were used to isolate and identify the bacteria. Total of 106 upper respiratory tract samples were collected from patients in Teba, Dhamar, Dar Al-Shefa, Salama, and Al Mosali hospitals also from Mayas, Al Afara, and Sary clinics, from November 2019 to March 2020. The results showed that the Streptococcus pyogenes recorded the highest rate of infection (34.9%). Followed by 26.6% of Staphylococcus aureus and Moraxella catarrhalis, then 3.6% of Streptococcus pneumoniae, Klebsiella pneumoniae and Pseudomonas aeruginosa, in addition to 0.9% of Haemophilus influenzae. The Incidence of URTI bacteria during period of study recorded the highest rate in March. The highest percentage of patients with URTI based on the sampling sites was recorded in Dar Al-Shefa and Teba hospitals. In addition, study indicated that the throat infections were highly spreading among males, while the otitis was greatly prevalent among the females. Moreover, the highest percentage of URTI was noted in age group between one to eleven years. Additionally, there is a considerable high resistance to some antimicrobial agents, often used in treatment of URTI, especially ceftriaxone, and azithromycin. The most effective antibacterial agents against all isolated URTI pathogens were gentamicin, amikacin and amoxyclav.

Key-Words / Index Term :
Isolation; Identification; Antibiotic susceptibility; Bacteria; Upper respiratory tract infections

References :
[1] M. Mucia, P. Salvago, A. Brancato, C. Cannizzaro, E. Cannizzaro,"Upper Respiratory Tract Infections in Children: From Case History to Management," Acta Medica Mediterranea, Vol.31, Issue 2, pp. 419– 424, 2015.
[2] S. Thapa, S. Sangita, G. A. Shishir, L. Annavarapu, B. S. Lokendra, A. Shamshul, G. Rajendra, S.Shrestha, N. Puja , "Burden of bacterial upper respiratory tract pathogens in school children of Nepal." BMJ open respiratory research, Vol. 4, Issue1, 2017.
[3] B. M. Mshelia, G. O. Adeshina, J. A. Onaolapo,"Comparative study of antibacterial efficacy of honey, lemon juice and standard antibiotic formulations against Staphylococcus aureus isolates from respiratory tract infections" Acta Scientific Microbiology, Vol.1, Issue 8, pp. 69– 76, 2018.?
[4] A. Jama-Kmiecik, A., M. Frej-M?drzak, J. Sarowska, and I. Choroszy-Król. "Pathogens causing upper respiratory tract infections in outpatients." In Pulmonary Dysfunction and Disease, pp. 89-93. Springer, Cham, 2016.
[5] A. Atia, N. Elyounsi, A. Abired, A. Wanis, A. Ashour, "Antibiotic Resistance Pattern of Bacteria Isolated from patients with upper respiratory tract infections; a four year study in Tripoli city" Indian Journal of Pathology and Microbiology, Vol. 54, Issue 4, pp 69-76, 2018.
[6] M. M. Pettigrew, F. Janneane, B. Richard, L. Aaron, N. Johanna, C. Tasnee. "Viral-bacterial interactions and risk of acute otitis media complicating upper respiratory tract infection." Journal of clinical microbiology, Vol. 49, Issue 11, pp. 3750-3755, 2011.
[7] A. M. Harris, A. H. Lauri, Q. Amir. "Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American College of Physicians and the Centers for Disease Control and Prevention." Annals of internal medicine, Vol.164, Issue 6, pp. 425-434, 2016.
[8] CDC (Centers for Disease Control and Prevention),"Antibiotic Resistance Threats in the United States. Atlanta, GA" Centers for Disease Control and Prevention; 2014. Accessed at www.cdc.gov/drug resistance/threat-report-2013 on 25 September 2015
[9] L. A. Hicks, C. Yu-Wen, H. T. Thomas, H. Michael, P. K. Keith "Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996–2003." Clinical Infectious Diseases, Vol. 53, 2003.
[10] U. P. M. Ashik, W. M. A Wan Daud. "Stabilization of Ni, Fe, and Co nanoparticles through modified Stöber method to obtain excellent catalytic performance: preparation, characterization, and catalytic activity for methane decomposition." Journal of the Taiwan Institute of Chemical Engineers, Vol. 61, pp.247-260, 2016.
[11] K. Revai, M. Dheeresh, C. Tasnee. "Association of nasopharyngeal bacterial colonization during upper respiratory tract infection and the development of acute otitis media." Clinical Infectious Diseases, Vol. 46, Issue 4, pp. e34-e37, 2008.
[12] L.Wang, X. Qiao, L. Ai, J. Zhai, X. Wang,"Isolation of antimicrobial resistant bacteria in upper respiratory tract infections of patients," Biotech, Vol.6, Issue2, pp166-172, 2016.?
[13] Y. D. Ashok, D. G. Neha, N. C. Vijay, S. B. Yogesh,"BanginwarAssessment of endophytic fungal isolates for its Antibiofilm activity on Pseudomonas aeruginosa," International Journal of Scientific Research in Biological Sciences, Vol.6, Issue.3, pp.81-86, 2019.
[14] H. Al-Dobaee, "Assessing the influence of climate change on cereal crop production in Dhamar Water and environment centre," Sana`a University, Sana’a, Yemen, http://www wec edu ye/wpcontent/uploads/2017/05/Lecture-13, 2016.
[15] H. Al Aizari, L. Ahamed, F. Mhammde, S. A. Saeed,"Quality assessment of ground water in Dhamar City, Yemen." International Journal of Environment, Vol 6, Issue 4, pp.56-71, 2017.
[16] A.K. Al-Mazrou, M.S. Atef, K. Walid, P. Jean-Yves, M. Cinzia,"A prospective, observational, epidemiological evaluation of the aetiology and antimicrobial susceptibility of acute otitis media in Saudi children younger than 5 years of age." Journal of epidemiology and global health, Vol. 4, Issue 3 pp. 231-238, 2014.
[17] M. Cheesbrough,"Medical laboratories manual for tropical countries." Tropical Health Technology and Butterworth London 2, p 479, 2002.
[18] M. Erifo Hibore, "Prevalence and Antibiotic Susceptibility Patterns of Selected Bacterial Uropathogens Among Patients With Urinary Tract Infection Cases in Wonji Hospital, Ethiopia’." PhD diss., Haramaya University, 2012.
[19] CLSI (Clinical Laboratory Standards Institute), "Performance standards for antimicrobial susceptibility testing," CLSI approved standard M100-S9, 2007.
[20] NCCLS, "Documented M02-A10 and M07-A8. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for E.coliATCC25922," 2010
[21] V. D. Sutton, D. S. Craig, D. H. David, S. Barry "Resistant bacteria in middle ear fluid at the time of tympanotomy tube surgery." Annals of Otology, Rhinology & Laryngology, Vol.109, Issue 1, pp. 24-29, 2000.
[22] V. A. Rezende, E. R. Almeida, R. F. Bento, E. L. Durigon, V. F. Botosso, Queiroz. "Estudo da flora bacteriana e viral na otite média secretora e rinofaringe na infância." Rev Bras Otorrinolaringol,Vol. 65, pp. 10-7, 1999
[23] C. Ashhurst-Smith, T. H. Sharron, J. B. Christine, S. John, C. B. Caroline, "Induction of inflammatory responses from THP-1 cells by cell-free filtrates from clinical isolates of Alloiococcus otitidis." Innate immunity, Vol 20, Issue 3, pp. 283-289, 2014.
[24] A. A. Palmu, T. J. Jukka, K. Tarja, L. Maija, K. Pekka, M. K. Terhi,"Association of clinical signs and symptoms with pneumococcal acute otitis media by serotype—implications for vaccine effect." Clinical infectious diseases, Volume 40, Issue 1, pp 52-57, 2005.
[25] J. D. Courter, L. B. William, S. N. Katherine, A. S. Lori, L. D. Lindsey, I. C. Craig, E. G. Jennifer, "Increased clinical failures when treating acute otitis media with macrolides: a meta-analysis." Annals of Pharmacotherapy, Vol. 44, Issue 3, pp. 471-478, 2010.
[26] S. Akter, S. M. Shamsuzzaman, N. Naznin, S. Ishrat, J. Ferdush, I. Saquebul,"Bacterial isolates and drug susceptibility patterns of ear discharge from patients with ear infection at Shaheed Monsur Ali Medical College." Bangladesh Journal of Medical Microbiology, Vol.9, Issue 2, pp. 20-23, 2015.
[27] F. J. Khayat, S. D. Lana, "Incidence of otitis media with effusion in children with adenoid hypertrophy," Zanco Journal of Medical Sciences, Vol.15, Issue 2, pp. 57-63, 2011.
[28] F. Al-Badaii, A. Abdul Halim. "Potential Risk Assessment of Drinking Water Source Exposed to Contamination Using Microbial Indicators and Multiple Antibiotic Resistance Index," Iranian (Iranica) Journal of Energy & Environment, Vol. 2, Issue 1, pp. 81-92, 2021
[29] K. Selvaraj, C. Palanivel, M. Anindo, S. K. Iswarya,"Acute respiratory infections among under-5 children in India: A situational analysis," Journal of natural science, biology, and medicine, Vol. 5, Issue 1, pp. 7-15, 2024
[30] M. A. Mohanna, A. B. Abdulrahman,"Bacterial profile and antibiogram of otitis media among children in Yemen," Journal of Ayub Medical College Abbottabad, Vol. 28, Issue 3, pp. 480-483, 2016.
[31] A. Rashid, C. Akhtaruzzaman, R. Sufi, A. B. Shahin, M. Naima Muazzam,"Infections by Pseudomonas aeruginosa and antibiotic resistance pattern of the isolates from Dhaka Medical College Hospital," Bangladesh Journal of Medical Microbiology, Vol. 1, Issue 2, pp. 48-51, 2007.
[32] G. Tesfaye, A. Daniel, W. Yimtubezinash, G. Messele. "Microbiology of discharging ears in Ethiopia." Asian Pacific Journal of Tropical Medicine, Vol. 2, Issue 1, pp. 60-67, 2009.
[33] K. Revai, M. Dheeresh, C. Tasnee. "Association of nasopharyngeal bacterial colonization during upper respiratory tract infection and the development of acute otitis media." Clinical Infectious Diseases, Vol. 46, Issue 4, pp. e34-e37, 2008.
[34] J. S. Ngocho, C. Amour, M. Sariko, B. T. Mmbaga, G. S. Kibiki, "Bacterial etiology of respiratory tract infections among ambulatory school children in Moshi Municipality, Tanzania," Science Journal of Public Health, Vol. 3, Issue 5, pp. 625-32, 2015.?
[35] C. Wong, L. Jayaram, N. Karalus, T. Eaton, C. Tong, H. Hockey, L. Storey,"Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial," The Lancet, Vol. 380, Issue 9842, pp. 660-667, 2012.
[36] F. Al-badaii, M. B. Gasim, M. Mokhtar, M. E. Toriman, S. A. Rahim,"Water- pollution study based on the physico-chemical and microbiological parameters of the Semenyih River, Selangor, Malaysia", The Arab World Geographer, Vol. 15, Issue 4, pp. 318-334, 2012.
[37] S. Sayyahfar, A. Fahimzad, A. Naddaf, S. Tavassoli,"Antibiotic susceptibility evaluation of group A streptococcus isolated from children with pharyngitis: a study from Iran," Infection & chemotherapy, Vol. 47, Issue 4, pp. 225-230, 2015.?
[38] E. Pérez-Trallero, C. Fernandez-Mazarrasa, C. Garc?a-Rey, E. Bouza, L. Aguilar, J. Garc?a-de-Lomas,"Antimicrobial Susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes Isolates and Their Ecological Relationships: Results of a 1-Year (1998–1999) Multicenter Surveillance Study in Spain," Antimicrobial agents and chemotherapy, Vol. 45, Issue 12, pp. 3334-3340, 2001.
[39] F. Khademi, H. Vaez, A. Sahebkar, R. A. Taheri, I. Zabol "Group a streptococcus antibiotic resistance in Iranian children: A meta-analysis," Oman Medical Journal. Vol. 35, Issue 5, pp. 1-14, 2020.
[40] T. Schwartz, W. Kohnen, B. Jansen, U. Obst,"Detection of antibiotic-resistant bacteria and their resistance genes in wastewater, surface water, and drinking water biofilms." FEMS microbiology ecology, Vol. 43, Issue 3, pp. 325-335, 2003.
[41] N. Gupta, Naveen, S. Arora, S. Kundra,"Moraxella catarrhalis as a respiratory pathogen." Indian Journal of Pathology and Microbiology, Vol. 54, Issue 4, pp. 760-769, 2011.
[42] S. Babakhani, D. Shokri, M. Nazer, M. Kazemi,"The frequency and pattern of antibiotic resistance among Klebsiella spp. isolated from nosocomial infection in Khorramabad hospital," Report of Health Care, Vol. 1, Issue 1, pp.1-5, 2014.
[43] O. Orole,"Characterization and Plasmid Profile of Resistant Klebsiella pneumoniae Isolates in Patients with Urinary Tract Infection in Nasarawa State Nigeria," International Journal of Applied Sciences and Biotechnology, Vol. 8, Issue 1, pp. 21-28, 2020.
[44] K. Lee, M. N. Kim, J. S. Kim, H. L.Hong, J. O. Kang, J. H. Shin, Y. J. Park, "Further increases in carbapenem-, amikacin-, and fluoroquinolone-resistant isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR study 2009." Yonsei medical journal, Vol. 52, Issue 5, pp. 785-793, 2011.
[45] Y. Bernal-Rosas, K. Osorio-Muñoz, O. Torres-García."Pseudomonas aeruginosa: an emerging nosocomial trouble in veterinary." Revista MVZ Córdoba, Vol. 20, pp. 4937-4946, 2015.
[46] G. F. Gad, R. A. El-Domany, S. Zaki, H. M. Ashour,"Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms," Journal of antimicrobial chemotherapy, Vol. 60, Issue 5, pp. 1010-1017, 2007.